Literature DB >> 18059030

HPP1-mediated tumor suppression requires activation of STAT1 pathways.

Abul Elahi1, Li Zhang, Timothy J Yeatman, Sigal Gery, Said Sebti, David Shibata.   

Abstract

HPP1 is a recently discovered gene that is epigenetically silenced in a number of tumor types, suggesting a potential role as a tumor suppressor. However, whether HPP1 has tumor suppressor activity is not clearly known. We have sought to investigate the effects of HPP1 on tumor growth and survival and to identify signaling pathways that mediate HPP1's mechanism of action. Forced expression of HPP1 into HCT116 colon cancer cell lines blocked the ability of HCT116 tumors to grown in vivo in nude mice. In cell culture, ectopic expression of HPP1 induces apoptosis and potently inhibits soft agar colony formation. HPP1 overexpression was also associated with a moderate reduction in in vitro proliferation characterized by an accumulation of cells in the G0/G1 phase of the cell cycle. Microarray analysis revealed that ectopic expression of HPP1 resulted in a dramatic upregulation of STAT1 as well as a large number of associated interferon-inducible genes. RNA interference-mediated abrogation of STAT1 reversed HPP1's antiproliferative effects. We conclude that HPP1 demonstrates tumor suppressive and pro-apoptotic activity, both in vitro and in vivo. Coupled with its inactivation in a number of tumor types, our data provides evidence to support the role of HPP1 as a tumor suppressor gene. Moreover, activation of the STAT1 pathway likely represents the principal mediator of HPP1's tumor suppressive properties. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18059030     DOI: 10.1002/ijc.23202

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Refined mapping of blood pressure quantitative trait loci using congenic strains developed from two genetically hypertensive rat models.

Authors:  Sivarajan Kumarasamy; Kathirvel Gopalakrishnan; Edward J Toland; Shane Yerga-Woolwine; Phyllis Farms; Eric E Morgan; Bina Joe
Journal:  Hypertens Res       Date:  2011-08-04       Impact factor: 3.872

2.  The Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways.

Authors:  Jonathan M Hernandez; Abul Elahi; Whalen Clark; Leigh Ann Humphries; Jian Wang; Alex Achille; Ed Seto; David Shibata
Journal:  DNA Cell Biol       Date:  2015-05-19       Impact factor: 3.311

3.  Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.

Authors:  Su Man Lee; Jae Yong Park; Dong Sun Kim
Journal:  Mol Cells       Date:  2012-07-18       Impact factor: 5.034

4.  HPP1 Ectodomain Shedding is Mediated by ADAM17 and is Necessary for Tumor Suppression in Colon Cancer.

Authors:  Abul Elahi; Abidemi Ajidahun; Leah Hendrick; Irina Getun; Leigh Ann Humphries; Jonathan Hernandez; David Shibata
Journal:  J Surg Res       Date:  2020-05-22       Impact factor: 2.192

5.  TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.

Authors:  Thomas Green; Xiaofei Chen; Stephen Ryan; Adam S Asch; Maria J Ruiz-Echevarría
Journal:  Prostate       Date:  2013-07-03       Impact factor: 4.104

6.  Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.

Authors:  Juan L Garcia; Maria Perez-Caro; Juan A Gomez-Moreta; Francisco Gonzalez; Javier Ortiz; Oscar Blanco; Magdalena Sancho; Jesus M Hernandez-Rivas; Rogelio Gonzalez-Sarmiento; Manuel Sanchez-Martin
Journal:  BMC Cancer       Date:  2010-08-24       Impact factor: 4.430

7.  Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer.

Authors:  Joshua M Corbin; Ryan F Overcash; Jonathan D Wren; Anita Coburn; Greg J Tipton; Jennifer A Ezzell; Kirk K McNaughton; Kar-Ming Fung; Stanley D Kosanke; Maria J Ruiz-Echevarria
Journal:  Prostate       Date:  2015-09-29       Impact factor: 4.104

8.  The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer.

Authors:  Jian Wang; Abul Elahi; Abidemi Ajidahun; Whalen Clark; Jonathan Hernandez; Alex Achille; Ji-hui Hao; Edward Seto; David Shibata
Journal:  Cancer Biol Ther       Date:  2014-06-11       Impact factor: 4.742

9.  TMEFF2 modulates the AKT and ERK signaling pathways.

Authors:  Xiaofei Chen; Maria J Ruiz-Echevarría
Journal:  Int J Biochem Mol Biol       Date:  2013-07-29

10.  HPP1 gene promoter methylation in pancreatic cancer: correlation with carcinogenesis and clinical implication.

Authors:  Lisi Peng; Lu Zhuang; Kun Lin; Yao Yao; Yang Zhang; Chunping Zhu; Kaixuan Wang; Haojie Huang; Zhaoshen Li
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.